Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zurampic
Fierce Biotech
Novo Holdings-backed biotech raises $205M to fill gout care gap
Crystalys and its team of 10 people—and growing—is pushing ahead in hopes of filling the treatment gap for patients with gout.
Gabrielle Masson
Sep 30, 2025 8:00am
Ironwood dumps AZ gout drug Zurampic and lays off 125
Aug 6, 2018 12:25pm
Ironwood zeroes in on primary care with new gout combo Duzallo
Aug 23, 2017 9:52am
Ironwood's gout franchise gets a lift with Duzallo combo OK
Aug 21, 2017 12:34pm
AZ inks $250M Zoladex deal in latest closet cleanout
Feb 21, 2017 7:39am
AZ jilts gout med Zurampic with $230M rights sale to Grunenthal
Jun 2, 2016 11:41am
